Anirban Basu | |
|---|---|
| Born | India |
| Alma mater | |
| Known for | Studies onJapanese encephalitis |
| Awards |
|
| Scientific career | |
| Fields | |
| Institutions | |
Anirban Basu is an Indian neurobiologist, who is primarily interested in neurovirology, a senior scientist at theNational Brain Research Centre, a deemed to be university, located in Manesar,Gurgaon,Haryana. He is internationally known for his studies onJapanese encephalitis. Basu is an elected fellow of all the three major Indian science Academies namely theIndian Academy of Sciences, theIndian National Science Academy and theNational Academy of Sciences, India as well as of the West Bengal Academy of Science and Technology. TheDepartment of Biotechnology of the Government of India awarded him theNational Bioscience Award for Career Development, one of the prominent Indian science awards, for his contributions to biosciences and biotechnology, in 2010.
Anirban Basu completed his undergraduate studies (BSc Hons) in 1991 and post graduate course (MSc) in 1993 at the School of Life Sciences of theViswa Bharati University .[1] His doctoral studies were at theCSIR-Indian Institute of Chemical Biology and later, he has done his postdoctoral studies at thePenn State Milton S. Hershey Medical Center, Hershey, Pennsylvania.[2] Returning to India, he joined theNational Brain Research Centre (NBRC) in 2004 as a scientist and a member of its faculty.[3] At NBRC, presently he serves as a senior scientist and has established an independent laboratory to study different aspects of neurotropic viral infection of brain.[4]
Basu resides inside the campus of National Brain Research Center, Manesar.
Basu's research focus is oncentral nervous system diseases (CNS diseases) and he has studied thecentral nervous system with regard to howmicroglia and neural stem/progenitor cells affect the system.[5] The team led by him are involved in research on thepathogenesis of viruses such asJapanese encephalitis virus (JEV), West Nile Virus (WNV) andChandipura virus (CHPV) and how they cause neuronal damage in hosts.[6] In 2011, his group identifiedminocycline, abroad-spectrumtetracycline antibiotic generally used for treating skin infections, as having properties in fighting the disease ofJapanese encephalitis, which they discovered through their experiments on mice.[7] The findings were put on clinical trial at theKing George's Medical University where it was found to have beneficial effect on Japanese encephalitis andAcute encephalitis syndrome patients who survive the initial attack of the diseases and this has led to a wider study on the subject.[5] He was the guest editor forClinical and Developmental Immunology journal when they released a special issue onMicroglia in Development and Disease in 2013[2] and has mentored several research scholars in the post-graduate, doctoral and post-doctoral studies.[5]
Basu serves as a member of theFaculty of 1000 at their division dealing with infectious diseases of the nervous system.[8] He is also part of the editorial board of journals such as theJournal of Neurochemistry,[9]Scientific Reports,[10]Journal of Neuroinflammation,[11] andFrontiers in Molecular Neuroscience[12]
TheDepartment of Biotechnology (DBT) of the Government of India awarded him theNational Bioscience Award for Career Development, one of the prominent Indian science awards in 2010.[13] TheNational Academy of Sciences, India elected him as a fellow in 2011[14] and he received theVASVIK Industrial Research Award the same year.[15] He was chosen for the Rajib Goyal Prize ofKurukshetra University in 2012,[16] the same year as he became an elected fellow of the West Bengal Academy of Science and Technology, and a year later, he received theNASI-Reliance Industries Platinum Jubilee Award.[17] He was awarded the Sreenivasaya Memorial Award of Society of Biological Chemists (India) in 2017[18] and two of the other major Indian science academies, theIndian National Science Academy[5] and theIndian Academy of Sciences elected him as their fellow in 2017 and 2018 respectively[19] He held the Tata Innvovation fellowship of the Department of Biotechnology in 2015 and the award orations delivered by him included the 2011 edition of the Dr. J. B. Srivastav Oration of theIndian Council of Medical Research,[20] the Senior Scientist Oration of the Indian Immunology Society in 2015[21] Prof. S. S. Katiyar Endowment Lecture of theIndian Science Congress Association in 2018.[5] In 2019, he has been elected to Fellowship in the American Academy of Microbiology (AAM). The AAM is the honorific leadership group within the American Society for Microbiology (ASM), the world's oldest and largest life science organization.
| International | |
|---|---|
| National | |
| Academics | |
